(a)  The pharmacist shall report any potential drug therapy irregularities or discrepancies in drug accountability and administration with recommendations for change to the director of nursing and the attending physician.  Recommendations shall be communicated to the health care professionals in the facility who have the authority to effect a change.  These reports shall be submitted monthly following the pharmacist's pharmaceutical care assessments.

(b)  The administrator shall ensure documentation of action taken relative to the pharmacist's reports.


History Note:        Authority G.S. 131E‑104; 131E-117;

Eff. January 1, 1996;

Pursuant to G.S. 150B-21.3A, rule is necessary without substantive public interest Eff. March 22, 2015.